Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$338K Sell
24,962
-15,956
-39% -$237K ﹤0.01% 2805
2026
Q1
$629K Buy
40,918
+28,415
+227% +$473K 0.01% 1815
2025
Q4
$226K Sell
12,503
-3,248
-21% -$55.9K 0.01% 2308
2025
Q3
$254K Buy
+15,751
New +$230K 0.01% 1642
2025
Q1
Sell
-14,288
Closed -$283K 2803
2024
Q4
$283K Buy
+14,288
New +$158K 0.02% 1276
2024
Q3
Sell
-15,063
Closed -$103K 2394
2024
Q2
$103K Buy
+15,063
New +$103K 0.01% 1414
2024
Q1
Sell
-5,424
Closed -$11.9K 2133
2023
Q4
$11.9K Buy
+5,424
New +$12.9K ﹤0.01% 1414

Other funds holding MESO

XTX Topco's MESO Position: Q2 2026 in Review

XTX Topco reduced its Mesoblast (MESO) stake by 39% in Q2 2026, selling an estimated $237K and leaving 24,962 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #2805.

XTX Topco first reported a position in MESO in Q4 2023 and has held it in 7 quarters since. The position peaked at $629K in Q1 2026. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • XTX Topco held 24,962 shares of Mesoblast worth $338K as of Q2 2026.
  • XTX Topco sold 15,956 Mesoblast shares in Q2 2026, an estimated $237K.
  • Mesoblast made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2805 holding.
  • XTX Topco first reported a position in Mesoblast in Q4 2023 and has held it in 7 quarters since.
  • XTX Topco's Mesoblast position peaked at $629K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.